Amendment of the Warrant. The Warrant is hereby amended as follows:
Amendment of the Warrant. Contemporaneous with the execution and delivery of this Agreement by all of the parties hereto, (i) SB Bio shall deliver to Antex the original Warrant and (ii) Antex shall deliver to SB Bio a duly executed Amended and Restated Warrant in the form of Exhibit C attached hereto.
Amendment of the Warrant. (a) The Expiration Date “[CURRENT EXPIRATION DATE]” in the heading of the Warrant is hereby amended and restated to read in its entirety as “[NEW EXPIRATION DATE]”.
Amendment of the Warrant. The phrase in the first sentence of Section (a) before the defined term “(the “Exercise Period”)” is deleted in its entirety and replaced with the following: “This Warrant may be exercised in whole or in part at any time or from time to time from the date hereof up to and including December 31, 2025”
Amendment of the Warrant. The Warrant is hereby amended to change the Exercise Price from $1.0350702 per share of Common Stock to the following:
Amendment of the Warrant. Contemporaneously with the execution of this Agreement, the parties shall execute the First Amendment to the Warrant in substantially the form attached as Exhibit B with respect to each of the Warrants.
Amendment of the Warrant. The Warrant is hereby amended by deleting the introductory paragraph of the Warrant in its entirety and replacing it with the following: "For value received, Dyadic International, Inc., a Florida corporation (the "Company") hereby certifies that X (the "Holder") or his assign(s) is entitled to purchase from the Company, at any time or from time to time during the Exercise Period (as defined below), in whole or in part, up to _________ shares of Common Stock, no par value, of the Company, at the price per share equal to $3.33 (the "Exercise Price")."
Amendment of the Warrant. Solazyme and Bunge hereby amend the terms of the Warrant as provided below. To the extent that the Warrant is explicitly amended by this Amendment, the terms of this Amendment will control over terms of the Warrant that are contrary to, or conflict with, this Amendment. Where the Warrant is not explicitly amended, the terms of the Warrant will remain in force. Initially capitalized terms used in this Amendment that are not otherwise defined herein shall have the meanings given to such terms in the Warrant.
Amendment of the Warrant. (a) The Parties hereby amend and replace Section 2(a) of the Warrant with the following language: “Transferability of Warrant. You agree that the Warrant is being acquired as an investment and not with a view to distribution thereof and that the Warrant may not be transferred, sold, assigned or hypothecated except as provided herein. You further acknowledge that the Warrant may not be transferred, sold, assigned or hypothecated unless pursuant to a registration statement that has become effective under the Securities Act of 1933, as amended (the “Act”), setting forth the terms of such offering and other pertinent data with respect thereto, or unless you have provided the Company with an acceptable opinion from acceptable counsel that such registration is not required. Certificates representing the Warrant shall bear an appropriate legend. Notwithstanding the foregoing, any request to transfer the Warrant must be accompanied by the Form of Assignment and Transfer attached hereto as Schedule 5 executed by the Warrant Holder.”
